Author:
Isa Shun-Ichi,Kawaguchi Tomoya,Teramukai Satoshi,Minato Koichi,Ohsaki Yoshinobu,Shibata Kazuhiko,Yonei Toshirou,Hayashibara Kenji,Fukushima Masanori,Kawahara Masaaki,Furuse Kiyoyuki,Mack Philip C.
Subject
Pulmonary and Respiratory Medicine,Oncology
Reference26 articles.
1. Number of Deaths and Proportional Mortality Rates from Malignant Neoplasms by Site in Japan (2005);‘Cancer Statistics in Japan’ Editorial Board,2005
2. Cancer statistics, 2001;Greenlee;CA Cancer J Clin,2001
3. Trends in lung cancer incidence by histological type in Osaka, Japan;Toyoda;Jpn J Clin Oncol,2008
4. Vinorelbine plus gemcitabine followed by docetaxel versus carboplatin plus paclitaxel in patients with advanced non-small-cell lung cancer: a randomised, open-label, phase III study;Kubota;Lancet Oncol,2008
5. Gandara TK, Crowley JJ, Moon J, et al. Pharmacogenomic (PG) analysis of Japan-SWOG common arm study in advanced stage non-small cell lung cancer (NSCLC): a model for testing population-related pharmacogenomics. Presented at American Society of Clinical Oncology Annual Meeting, Chicago, June 1–5, 2007.